John C. Sheehan

John C. Sheehan, who in 1957 chemically synthesized penicillin, a feat that had been thought impossible, died March 21 of congestive heart failure at his home in Key Biscayne, Fla. He was 76 years old. Sheehan, a professor of organic chemistry, emeritus, at the Massachusetts Institute of Technology, taught at that school for 31 years. He joined the faculty there as an assistant professor in 1946 and in 1948 began working on the synthesis of penicillin. The formation of a just small amount of n

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

John C. Sheehan, who in 1957 chemically synthesized penicillin, a feat that had been thought impossible, died March 21 of congestive heart failure at his home in Key Biscayne, Fla. He was 76 years old.

Sheehan, a professor of organic chemistry, emeritus, at the Massachusetts Institute of Technology, taught at that school for 31 years. He joined the faculty there as an assistant professor in 1946 and in 1948 began working on the synthesis of penicillin. The formation of a just small amount of natural penicillin from mold took months, which proved inefficient during World War II, when demand for the antibiotic escalated.

Sheehan worked for nine years on penicillin synthesis. His work made possible the creation of different, bacteria- specific penicillin drugs. Eventually, improvements in fermentation technology made possible the commercial production of penicillin.

Sheehan was the discoverer of ampicillin, a semisynthetic penicillin taken orally. His research also focused ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies